ENDONOVO THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $46.00K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-03-31 was $207.00K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $20.49K, a 79.51% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $126.00K.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $142.00K, a 12.70% increase from fiscal 2021.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2021 was $126.00K, a 26.00% increase from fiscal 2020.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2020 was $100.00K, a 40.60% decline from fiscal 2019.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2019 was $168.34K, a 573.37% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-06-30 | $46.00K 10-Q · filed 2023-12-29 | |
| 2023-03-31 | $207.00K 10-Q · filed 2023-12-29 | |
| 2022-12-31 | $142.00K 10-K · filed 2023-04-17 | |
| 2021-12-31 | $126.00K 10-K · filed 2023-04-17 | |
| 2021-09-30 | $20.49K 10-Q · filed 2021-11-19 | |
| 2021-03-31 | $126.00K 10-Q · filed 2022-11-21 | |
| 2020-12-31 | $100.00K 10-K · filed 2022-04-14 | |
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-19 | |
| 2019-12-31 | $168.34K 10-K · filed 2021-04-13 | |
| 2019-09-30 | $10.00K 10-Q · filed 2020-11-19 | -$38.89K derived: sum of 4 quarters · filed 2020-11-19 |
| 2019-06-30 | $33.55K 10-Q · filed 2020-11-19 | -$48.89K derived: sum of 4 quarters · filed 2020-11-19 |
| 2019-03-31 | $27.56K 10-Q · filed 2020-11-19 | -$82.44K derived: sum of 4 quarters · filed 2020-11-19 |
| 2018-12-31 | -$110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-04 | $25.00K 10-K · filed 2020-05-04 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $135.00K derived: sum of 4 quarters · filed 2019-04-15 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | |
| 2018-03-31 | $135.00K 10-Q · filed 2018-05-18 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2019-04-15 | $5.00 10-K · filed 2019-04-15 |
| 2016-12-31 | $1.13M 10-K · filed 2017-04-17 |